- IBDEI06C ; ; 01-AUG-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,15368,2)
- ;;=^5001908
- ;;^UTILITY(U,$J,358.3,15369,0)
- ;;=C45.0^^56^644^175
- ;;^UTILITY(U,$J,358.3,15369,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15369,1,3,0)
- ;;=3^Mesothelioma of Pleura
- ;;^UTILITY(U,$J,358.3,15369,1,4,0)
- ;;=4^C45.0
- ;;^UTILITY(U,$J,358.3,15369,2)
- ;;=^5001095
- ;;^UTILITY(U,$J,358.3,15370,0)
- ;;=C90.01^^56^644^177
- ;;^UTILITY(U,$J,358.3,15370,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15370,1,3,0)
- ;;=3^Multiple Myeloma,In Remission
- ;;^UTILITY(U,$J,358.3,15370,1,4,0)
- ;;=4^C90.01
- ;;^UTILITY(U,$J,358.3,15370,2)
- ;;=^267515
- ;;^UTILITY(U,$J,358.3,15371,0)
- ;;=C90.00^^56^644^178
- ;;^UTILITY(U,$J,358.3,15371,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15371,1,3,0)
- ;;=3^Multiple Myeloma,Not in Remission
- ;;^UTILITY(U,$J,358.3,15371,1,4,0)
- ;;=4^C90.00
- ;;^UTILITY(U,$J,358.3,15371,2)
- ;;=^5001752
- ;;^UTILITY(U,$J,358.3,15372,0)
- ;;=C94.6^^56^644^179
- ;;^UTILITY(U,$J,358.3,15372,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15372,1,3,0)
- ;;=3^Myelodysplastic Disease NEC
- ;;^UTILITY(U,$J,358.3,15372,1,4,0)
- ;;=4^C94.6
- ;;^UTILITY(U,$J,358.3,15372,2)
- ;;=^5001846
- ;;^UTILITY(U,$J,358.3,15373,0)
- ;;=D61.82^^56^644^180
- ;;^UTILITY(U,$J,358.3,15373,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15373,1,3,0)
- ;;=3^Myelophthisis
- ;;^UTILITY(U,$J,358.3,15373,1,4,0)
- ;;=4^D61.82
- ;;^UTILITY(U,$J,358.3,15373,2)
- ;;=^334037
- ;;^UTILITY(U,$J,358.3,15374,0)
- ;;=D47.9^^56^644^181
- ;;^UTILITY(U,$J,358.3,15374,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15374,1,3,0)
- ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
- ;;^UTILITY(U,$J,358.3,15374,1,4,0)
- ;;=4^D47.9
- ;;^UTILITY(U,$J,358.3,15374,2)
- ;;=^5002260
- ;;^UTILITY(U,$J,358.3,15375,0)
- ;;=D53.9^^56^644^185
- ;;^UTILITY(U,$J,358.3,15375,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15375,1,3,0)
- ;;=3^Nutritional Anemia,Unspec
- ;;^UTILITY(U,$J,358.3,15375,1,4,0)
- ;;=4^D53.9
- ;;^UTILITY(U,$J,358.3,15375,2)
- ;;=^5002298
- ;;^UTILITY(U,$J,358.3,15376,0)
- ;;=D47.4^^56^644^186
- ;;^UTILITY(U,$J,358.3,15376,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15376,1,3,0)
- ;;=3^Osteomyelofibrosis
- ;;^UTILITY(U,$J,358.3,15376,1,4,0)
- ;;=4^D47.4
- ;;^UTILITY(U,$J,358.3,15376,2)
- ;;=^5002259
- ;;^UTILITY(U,$J,358.3,15377,0)
- ;;=D51.3^^56^644^210
- ;;^UTILITY(U,$J,358.3,15377,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15377,1,3,0)
- ;;=3^Vitamin B12 Deficiency Anemia,Other
- ;;^UTILITY(U,$J,358.3,15377,1,4,0)
- ;;=4^D51.3
- ;;^UTILITY(U,$J,358.3,15377,2)
- ;;=^5002287
- ;;^UTILITY(U,$J,358.3,15378,0)
- ;;=D77.^^56^644^62
- ;;^UTILITY(U,$J,358.3,15378,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15378,1,3,0)
- ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
- ;;^UTILITY(U,$J,358.3,15378,1,4,0)
- ;;=4^D77.
- ;;^UTILITY(U,$J,358.3,15378,2)
- ;;=^5002396
- ;;^UTILITY(U,$J,358.3,15379,0)
- ;;=D58.2^^56^644^88
- ;;^UTILITY(U,$J,358.3,15379,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15379,1,3,0)
- ;;=3^Hemoglobinopathies,Other
- ;;^UTILITY(U,$J,358.3,15379,1,4,0)
- ;;=4^D58.2
- ;;^UTILITY(U,$J,358.3,15379,2)
- ;;=^87629
- ;;^UTILITY(U,$J,358.3,15380,0)
- ;;=C88.8^^56^644^110
- ;;^UTILITY(U,$J,358.3,15380,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15380,1,3,0)
- ;;=3^Malig Immunoproliferative Diseases,Other
- ;;^UTILITY(U,$J,358.3,15380,1,4,0)
- ;;=4^C88.8
- ;;^UTILITY(U,$J,358.3,15380,2)
- ;;=^5001750
- ;;^UTILITY(U,$J,358.3,15381,0)
- ;;=D70.8^^56^644^183
- ;;^UTILITY(U,$J,358.3,15381,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15381,1,3,0)
- ;;=3^Neutropenia,Other
- ;;^UTILITY(U,$J,358.3,15381,1,4,0)
- ;;=4^D70.8
- ;;^UTILITY(U,$J,358.3,15381,2)
- ;;=^334042
- ;;^UTILITY(U,$J,358.3,15382,0)
- ;;=D59.4^^56^644^184
- ;;^UTILITY(U,$J,358.3,15382,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15382,1,3,0)
- ;;=3^Nonautoimmune Hemolytic Anemias,Other
- ;;^UTILITY(U,$J,358.3,15382,1,4,0)
- ;;=4^D59.4
- ;;^UTILITY(U,$J,358.3,15382,2)
- ;;=^5002326
- ;;^UTILITY(U,$J,358.3,15383,0)
- ;;=D69.59^^56^644^190
- ;;^UTILITY(U,$J,358.3,15383,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15383,1,3,0)
- ;;=3^Secondary Thrombocytopenia,Other
- ;;^UTILITY(U,$J,358.3,15383,1,4,0)
- ;;=4^D69.59
- ;;^UTILITY(U,$J,358.3,15383,2)
- ;;=^5002369
- ;;^UTILITY(U,$J,358.3,15384,0)
- ;;=C22.7^^56^644^51
- ;;^UTILITY(U,$J,358.3,15384,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15384,1,3,0)
- ;;=3^Carcinomas of Liver,Other Spec
- ;;^UTILITY(U,$J,358.3,15384,1,4,0)
- ;;=4^C22.7
- ;;^UTILITY(U,$J,358.3,15384,2)
- ;;=^5000938
- ;;^UTILITY(U,$J,358.3,15385,0)
- ;;=D75.89^^56^644^61
- ;;^UTILITY(U,$J,358.3,15385,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15385,1,3,0)
- ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
- ;;^UTILITY(U,$J,358.3,15385,1,4,0)
- ;;=4^D75.89
- ;;^UTILITY(U,$J,358.3,15385,2)
- ;;=^5002392
- ;;^UTILITY(U,$J,358.3,15386,0)
- ;;=D47.Z9^^56^644^182
- ;;^UTILITY(U,$J,358.3,15386,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15386,1,3,0)
- ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
- ;;^UTILITY(U,$J,358.3,15386,1,4,0)
- ;;=4^D47.Z9
- ;;^UTILITY(U,$J,358.3,15386,2)
- ;;=^5002262
- ;;^UTILITY(U,$J,358.3,15387,0)
- ;;=D05.82^^56^644^39
- ;;^UTILITY(U,$J,358.3,15387,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15387,1,3,0)
- ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
- ;;^UTILITY(U,$J,358.3,15387,1,4,0)
- ;;=4^D05.82
- ;;^UTILITY(U,$J,358.3,15387,2)
- ;;=^5001934
- ;;^UTILITY(U,$J,358.3,15388,0)
- ;;=D05.81^^56^644^41
- ;;^UTILITY(U,$J,358.3,15388,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15388,1,3,0)
- ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
- ;;^UTILITY(U,$J,358.3,15388,1,4,0)
- ;;=4^D05.81
- ;;^UTILITY(U,$J,358.3,15388,2)
- ;;=^5001933
- ;;^UTILITY(U,$J,358.3,15389,0)
- ;;=D05.80^^56^644^43
- ;;^UTILITY(U,$J,358.3,15389,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15389,1,3,0)
- ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
- ;;^UTILITY(U,$J,358.3,15389,1,4,0)
- ;;=4^D05.80
- ;;^UTILITY(U,$J,358.3,15389,2)
- ;;=^5001932
- ;;^UTILITY(U,$J,358.3,15390,0)
- ;;=D56.8^^56^644^205
- ;;^UTILITY(U,$J,358.3,15390,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15390,1,3,0)
- ;;=3^Thalassemias,Other
- ;;^UTILITY(U,$J,358.3,15390,1,4,0)
- ;;=4^D56.8
- ;;^UTILITY(U,$J,358.3,15390,2)
- ;;=^5002305
- ;;^UTILITY(U,$J,358.3,15391,0)
- ;;=C82.89^^56^644^81
- ;;^UTILITY(U,$J,358.3,15391,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15391,1,3,0)
- ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
- ;;^UTILITY(U,$J,358.3,15391,1,4,0)
- ;;=4^C82.89
- ;;^UTILITY(U,$J,358.3,15391,2)
- ;;=^5001540
- ;;^UTILITY(U,$J,358.3,15392,0)
- ;;=D51.8^^56^644^212
- ;;^UTILITY(U,$J,358.3,15392,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15392,1,3,0)
- ;;=3^Vitamin B12 Deficiency Anemias,Other
- ;;^UTILITY(U,$J,358.3,15392,1,4,0)
- ;;=4^D51.8
- ;;^UTILITY(U,$J,358.3,15392,2)
- ;;=^5002288
- ;;^UTILITY(U,$J,358.3,15393,0)
- ;;=I80.9^^56^644^187
- ;;^UTILITY(U,$J,358.3,15393,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15393,1,3,0)
- ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
- ;;^UTILITY(U,$J,358.3,15393,1,4,0)
- ;;=4^I80.9
- ;;^UTILITY(U,$J,358.3,15393,2)
- ;;=^93357
- ;;^UTILITY(U,$J,358.3,15394,0)
- ;;=D45.^^56^644^188
- ;;^UTILITY(U,$J,358.3,15394,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15394,1,3,0)
- ;;=3^Polycythemia Vera
- ;;^UTILITY(U,$J,358.3,15394,1,4,0)
- ;;=4^D45.
- ;;^UTILITY(U,$J,358.3,15394,2)
- ;;=^96105
- ;;^UTILITY(U,$J,358.3,15395,0)
- ;;=C77.3^^56^644^117
- ;;^UTILITY(U,$J,358.3,15395,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15395,1,3,0)
- ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
- ;;^UTILITY(U,$J,358.3,15395,1,4,0)
- ;;=4^C77.3
- ;;^UTILITY(U,$J,358.3,15395,2)
- ;;=^5001330
- ;;^UTILITY(U,$J,358.3,15396,0)
- ;;=C77.2^^56^644^133
- ;;^UTILITY(U,$J,358.3,15396,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15396,1,3,0)
- ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
- ;;^UTILITY(U,$J,358.3,15396,1,4,0)
- ;;=4^C77.2
- ;;^UTILITY(U,$J,358.3,15396,2)
- ;;=^267316
- ;;^UTILITY(U,$J,358.3,15397,0)
- ;;=C77.1^^56^644^134
- ;;^UTILITY(U,$J,358.3,15397,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15397,1,3,0)
- ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
- ;;^UTILITY(U,$J,358.3,15397,1,4,0)
- ;;=4^C77.1
- ;;^UTILITY(U,$J,358.3,15397,2)
- ;;=^267315
- ;;^UTILITY(U,$J,358.3,15398,0)
- ;;=C77.0^^56^644^150
- ;;^UTILITY(U,$J,358.3,15398,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15398,1,3,0)
- ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
- ;;^UTILITY(U,$J,358.3,15398,1,4,0)
- ;;=4^C77.0
- ;;^UTILITY(U,$J,358.3,15398,2)
- ;;=^5001329
- ;;^UTILITY(U,$J,358.3,15399,0)
- ;;=C77.8^^56^644^151
- ;;^UTILITY(U,$J,358.3,15399,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15399,1,3,0)
- ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
- ;;^UTILITY(U,$J,358.3,15399,1,4,0)
- ;;=4^C77.8
- ;;^UTILITY(U,$J,358.3,15399,2)
- ;;=^5001332
- ;;^UTILITY(U,$J,358.3,15400,0)
- ;;=C79.51^^56^644^121
- ;;^UTILITY(U,$J,358.3,15400,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15400,1,3,0)
- ;;=3^Malig Neop Bone,Secondary
- ;;^UTILITY(U,$J,358.3,15400,1,4,0)
- ;;=4^C79.51
- ;;^UTILITY(U,$J,358.3,15400,2)
- ;;=^5001350
- ;;^UTILITY(U,$J,358.3,15401,0)
- ;;=C79.52^^56^644^120
- ;;^UTILITY(U,$J,358.3,15401,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15401,1,3,0)
- ;;=3^Malig Neop Bone Marrow,Secondary
- ;;^UTILITY(U,$J,358.3,15401,1,4,0)
- ;;=4^C79.52
- ;;^UTILITY(U,$J,358.3,15401,2)
- ;;=^5001351
- ;;^UTILITY(U,$J,358.3,15402,0)
- ;;=C79.31^^56^644^122
- ;;^UTILITY(U,$J,358.3,15402,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15402,1,3,0)
- ;;=3^Malig Neop Brain,Secondary
- ;;^UTILITY(U,$J,358.3,15402,1,4,0)
- ;;=4^C79.31
- ;;^UTILITY(U,$J,358.3,15402,2)
- ;;=^5001347
- ;;^UTILITY(U,$J,358.3,15403,0)
- ;;=C79.72^^56^644^137
- ;;^UTILITY(U,$J,358.3,15403,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15403,1,3,0)
- ;;=3^Malig Neop Left Adrenal Gland,Secondary
- ;;^UTILITY(U,$J,358.3,15403,1,4,0)
- ;;=4^C79.72
- ;;^UTILITY(U,$J,358.3,15403,2)
- ;;=^5001357
- ;;^UTILITY(U,$J,358.3,15404,0)
- ;;=C78.02^^56^644^141
- ;;^UTILITY(U,$J,358.3,15404,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15404,1,3,0)
- ;;=3^Malig Neop Left Lung,Secondary
- ;;^UTILITY(U,$J,358.3,15404,1,4,0)
- ;;=4^C78.02
- ;;^UTILITY(U,$J,358.3,15404,2)
- ;;=^5001336
- ;;^UTILITY(U,$J,358.3,15405,0)
- ;;=C78.7^^56^644^146
- ;;^UTILITY(U,$J,358.3,15405,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15405,1,3,0)
- ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
- ;;^UTILITY(U,$J,358.3,15405,1,4,0)
- ;;=4^C78.7
- ;;^UTILITY(U,$J,358.3,15405,2)
- ;;=^5001339
- ;;^UTILITY(U,$J,358.3,15406,0)
- ;;=C79.71^^56^644^159
- ;;^UTILITY(U,$J,358.3,15406,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15406,1,3,0)
- ;;=3^Malig Neop Right Adrenal Gland,Secondary
- ;;^UTILITY(U,$J,358.3,15406,1,4,0)
- ;;=4^C79.71
- ;;^UTILITY(U,$J,358.3,15406,2)
- ;;=^5001356
- ;;^UTILITY(U,$J,358.3,15407,0)
- ;;=C78.01^^56^644^163
- ;;^UTILITY(U,$J,358.3,15407,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15407,1,3,0)
- ;;=3^Malig Neop Right Lung,Secondary
- ;;^UTILITY(U,$J,358.3,15407,1,4,0)
- ;;=4^C78.01
- ;;^UTILITY(U,$J,358.3,15407,2)
- ;;=^5001335
- ;;^UTILITY(U,$J,358.3,15408,0)
- ;;=C79.70^^56^644^114
- ;;^UTILITY(U,$J,358.3,15408,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15408,1,3,0)
- ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
- ;;^UTILITY(U,$J,358.3,15408,1,4,0)
- ;;=4^C79.70
- ;;^UTILITY(U,$J,358.3,15408,2)
- ;;=^5001355
- ;;^UTILITY(U,$J,358.3,15409,0)
- ;;=C78.00^^56^644^147
- ;;^UTILITY(U,$J,358.3,15409,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15409,1,3,0)
- ;;=3^Malig Neop Lung Unspec,Secondary
- ;;^UTILITY(U,$J,358.3,15409,1,4,0)
- ;;=4^C78.00
- ;;^UTILITY(U,$J,358.3,15409,2)
- ;;=^5001334
- ;;^UTILITY(U,$J,358.3,15410,0)
- ;;=D57.1^^56^644^191
- ;;^UTILITY(U,$J,358.3,15410,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15410,1,3,0)
- ;;=3^Sickle-Cell Disease w/o Crisis
- ;;^UTILITY(U,$J,358.3,15410,1,4,0)
- ;;=4^D57.1
- ;;^UTILITY(U,$J,358.3,15410,2)
- ;;=^5002309
- ;;^UTILITY(U,$J,358.3,15411,0)
- ;;=D75.1^^56^644^189
- ;;^UTILITY(U,$J,358.3,15411,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15411,1,3,0)
- ;;=3^Polycythemia,Secondary
- ;;^UTILITY(U,$J,358.3,15411,1,4,0)
- ;;=4^D75.1
- ;;^UTILITY(U,$J,358.3,15411,2)
- ;;=^186856
- ;;^UTILITY(U,$J,358.3,15412,0)
- ;;=C90.30^^56^644^202
- ;;^UTILITY(U,$J,358.3,15412,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15412,1,3,0)
- ;;=3^Solitary Plasmacytoma,Not in Remission
- ;;^UTILITY(U,$J,358.3,15412,1,4,0)
- ;;=4^C90.30
- ;;^UTILITY(U,$J,358.3,15412,2)
- ;;=^5001759
- ;;^UTILITY(U,$J,358.3,15413,0)
- ;;=D56.3^^56^644^203
- ;;^UTILITY(U,$J,358.3,15413,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15413,1,3,0)
- ;;=3^Thalassemia Minor
- ;;^UTILITY(U,$J,358.3,15413,1,4,0)
- ;;=4^D56.3
- ;;^UTILITY(U,$J,358.3,15413,2)
- ;;=^340497
- ;;^UTILITY(U,$J,358.3,15414,0)
- ;;=D56.9^^56^644^204
- ;;^UTILITY(U,$J,358.3,15414,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15414,1,3,0)
- ;;=3^Thalassemia,Unspec
- ;;^UTILITY(U,$J,358.3,15414,1,4,0)
- ;;=4^D56.9
- ;;^UTILITY(U,$J,358.3,15414,2)
- ;;=^340606
- ;;^UTILITY(U,$J,358.3,15415,0)
- ;;=D51.2^^56^644^207
- ;;^UTILITY(U,$J,358.3,15415,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15415,1,3,0)
- ;;=3^Transcobalamin II Deficiency
- ;;^UTILITY(U,$J,358.3,15415,1,4,0)
- ;;=4^D51.2
- ;;^UTILITY(U,$J,358.3,15415,2)
- ;;=^5002286
- ;;^UTILITY(U,$J,358.3,15416,0)
- ;;=D05.92^^56^644^40
- ;;^UTILITY(U,$J,358.3,15416,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15416,1,3,0)
- ;;=3^Carcinoma in Situ Left Breast,Unspec Type
- ;;^UTILITY(U,$J,358.3,15416,1,4,0)
- ;;=4^D05.92
- ;;^UTILITY(U,$J,358.3,15416,2)
- ;;=^5001937
- ;;^UTILITY(U,$J,358.3,15417,0)
- ;;=D05.91^^56^644^42
- ;;^UTILITY(U,$J,358.3,15417,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15417,1,3,0)
- ;;=3^Carcinoma in Situ Right Breast,Unspec Type
- ;;^UTILITY(U,$J,358.3,15417,1,4,0)
- ;;=4^D05.91
- ;;^UTILITY(U,$J,358.3,15417,2)
- ;;=^5001936
- ;;^UTILITY(U,$J,358.3,15418,0)
- ;;=D05.90^^56^644^38
- ;;^UTILITY(U,$J,358.3,15418,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15418,1,3,0)
- ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
- ;;^UTILITY(U,$J,358.3,15418,1,4,0)
- ;;=4^D05.90
- ;;^UTILITY(U,$J,358.3,15418,2)
- ;;=^5001935
- ;;^UTILITY(U,$J,358.3,15419,0)
- ;;=D51.0^^56^644^208
- ;;^UTILITY(U,$J,358.3,15419,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15419,1,3,0)
- ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
- ;;^UTILITY(U,$J,358.3,15419,1,4,0)
- ;;=4^D51.0
- ;;^UTILITY(U,$J,358.3,15419,2)
- ;;=^5002284
- ;;^UTILITY(U,$J,358.3,15420,0)
- ;;=D51.1^^56^644^209
- ;;^UTILITY(U,$J,358.3,15420,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15420,1,3,0)
- ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
- ;;^UTILITY(U,$J,358.3,15420,1,4,0)
- ;;=4^D51.1
- ;;^UTILITY(U,$J,358.3,15420,2)
- ;;=^5002285
- ;;^UTILITY(U,$J,358.3,15421,0)
- ;;=D51.9^^56^644^211
- ;;^UTILITY(U,$J,358.3,15421,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15421,1,3,0)
- ;;=3^Vitamin B12 Deficiency Anemia,Unspec
- ;;^UTILITY(U,$J,358.3,15421,1,4,0)
- ;;=4^D51.9
- ;;^UTILITY(U,$J,358.3,15421,2)
- ;;=^5002289
- ;;^UTILITY(U,$J,358.3,15422,0)
- ;;=D68.0^^56^644^213
- ;;^UTILITY(U,$J,358.3,15422,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15422,1,3,0)
- ;;=3^Von Willebrand's Disease
- ;;^UTILITY(U,$J,358.3,15422,1,4,0)
- ;;=4^D68.0
- ;;^UTILITY(U,$J,358.3,15422,2)
- ;;=^127267
- ;;^UTILITY(U,$J,358.3,15423,0)
- ;;=C88.0^^56^644^214
- ;;^UTILITY(U,$J,358.3,15423,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15423,1,3,0)
- ;;=3^Waldenstrom Macroglobulinemia
- ;;^UTILITY(U,$J,358.3,15423,1,4,0)
- ;;=4^C88.0
- ;;^UTILITY(U,$J,358.3,15423,2)
- ;;=^5001748
- ;;^UTILITY(U,$J,358.3,15424,0)
- ;;=C91.02^^56^644^3
- ;;^UTILITY(U,$J,358.3,15424,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15424,1,3,0)
- ;;=3^Acute Lymphoblastic Leukemia,In Relapse
- ;;^UTILITY(U,$J,358.3,15424,1,4,0)
- ;;=4^C91.02
- ;;^UTILITY(U,$J,358.3,15424,2)
- ;;=^5001764
- ;;^UTILITY(U,$J,358.3,15425,0)
- ;;=C92.02^^56^644^6
- ;;^UTILITY(U,$J,358.3,15425,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15425,1,3,0)
- ;;=3^Acute Myeloblastic Leukemia,In Relapse
- ;;^UTILITY(U,$J,358.3,15425,1,4,0)
- ;;=4^C92.02
- ;;^UTILITY(U,$J,358.3,15425,2)
- ;;=^5001791
- ;;^UTILITY(U,$J,358.3,15426,0)
- ;;=D09.3^^56^644^50
- ;;^UTILITY(U,$J,358.3,15426,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15426,1,3,0)
- ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
- ;;^UTILITY(U,$J,358.3,15426,1,4,0)
- ;;=4^D09.3
- ;;^UTILITY(U,$J,358.3,15426,2)
- ;;=^5001955
- ;;^UTILITY(U,$J,358.3,15427,0)
- ;;=C22.0^^56^644^91
- ;;^UTILITY(U,$J,358.3,15427,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15427,1,3,0)
- ;;=3^Hepatocellular Carcinoma
- ;;^UTILITY(U,$J,358.3,15427,1,4,0)
- ;;=4^C22.0
- ;;^UTILITY(U,$J,358.3,15427,2)
- ;;=^5000933
- ;;^UTILITY(U,$J,358.3,15428,0)
- ;;=C24.9^^56^644^118
- ;;^UTILITY(U,$J,358.3,15428,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15428,1,3,0)
- ;;=3^Malig Neop Biliary Tract,Unspec
- ;;^UTILITY(U,$J,358.3,15428,1,4,0)
- ;;=4^C24.9
- ;;^UTILITY(U,$J,358.3,15428,2)
- ;;=^5000942
- ;;^UTILITY(U,$J,358.3,15429,0)
- ;;=C50.922^^56^644^142
- ;;^UTILITY(U,$J,358.3,15429,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15429,1,3,0)
- ;;=3^Malig Neop Left Male Breast,Unspec Site
- ;;^UTILITY(U,$J,358.3,15429,1,4,0)
- ;;=4^C50.922
- ;;^UTILITY(U,$J,358.3,15429,2)
- ;;=^5133340
- ;;^UTILITY(U,$J,358.3,15430,0)
- ;;=C34.91^^56^644^160
- ;;^UTILITY(U,$J,358.3,15430,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15430,1,3,0)
- ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
- ;;^UTILITY(U,$J,358.3,15430,1,4,0)
- ;;=4^C34.91
- ;;^UTILITY(U,$J,358.3,15430,2)
- ;;=^5000967
- ;;^UTILITY(U,$J,358.3,15431,0)
- ;;=C50.921^^56^644^164
- ;;^UTILITY(U,$J,358.3,15431,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15431,1,3,0)
- ;;=3^Malig Neop Right Male Breast,Unspec Site
- ;;^UTILITY(U,$J,358.3,15431,1,4,0)
- ;;=4^C50.921
- ;;^UTILITY(U,$J,358.3,15431,2)
- ;;=^5001198
- ;;^UTILITY(U,$J,358.3,15432,0)
- ;;=C90.02^^56^644^176
- ;;^UTILITY(U,$J,358.3,15432,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15432,1,3,0)
- ;;=3^Multiple Myeloma,In Relapse
- ;;^UTILITY(U,$J,358.3,15432,1,4,0)
- ;;=4^C90.02
- ;;^UTILITY(U,$J,358.3,15432,2)
- ;;=^5001753
- ;;^UTILITY(U,$J,358.3,15433,0)
- ;;=D51.9^^56^644^25
- ;;^UTILITY(U,$J,358.3,15433,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15433,1,3,0)
- ;;=3^Anemia in Vitamin B12 Deficiency
- ;;^UTILITY(U,$J,358.3,15433,1,4,0)
- ;;=4^D51.9
- ;;^UTILITY(U,$J,358.3,15433,2)
- ;;=^5002289
- ;;^UTILITY(U,$J,358.3,15434,0)
- ;;=C79.51^^56^644^35
- ;;^UTILITY(U,$J,358.3,15434,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15434,1,3,0)
- ;;=3^Bone Mets
- ;;^UTILITY(U,$J,358.3,15434,1,4,0)
- ;;=4^C79.51
- ;;^UTILITY(U,$J,358.3,15434,2)
- ;;=^5001350
- ;;^UTILITY(U,$J,358.3,15435,0)
- ;;=C80.1^^56^644^171
- ;;^UTILITY(U,$J,358.3,15435,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15435,1,3,0)
- ;;=3^Malig Neop,Primary,Unspec Site
- ;;^UTILITY(U,$J,358.3,15435,1,4,0)
- ;;=4^C80.1
- ;;^UTILITY(U,$J,358.3,15435,2)
- ;;=^5001389
- ;;^UTILITY(U,$J,358.3,15436,0)
- ;;=C80.0^^56^644^172
- ;;^UTILITY(U,$J,358.3,15436,1,0)
- ;;=^358.31IA^4^2
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI06C 19779 printed Feb 18, 2025@23:08:53 Page 2
- IBDEI06C ; ; 01-AUG-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,15368,2)
- +2 ;;=^5001908
- +3 ;;^UTILITY(U,$J,358.3,15369,0)
- +4 ;;=C45.0^^56^644^175
- +5 ;;^UTILITY(U,$J,358.3,15369,1,0)
- +6 ;;=^358.31IA^4^2
- +7 ;;^UTILITY(U,$J,358.3,15369,1,3,0)
- +8 ;;=3^Mesothelioma of Pleura
- +9 ;;^UTILITY(U,$J,358.3,15369,1,4,0)
- +10 ;;=4^C45.0
- +11 ;;^UTILITY(U,$J,358.3,15369,2)
- +12 ;;=^5001095
- +13 ;;^UTILITY(U,$J,358.3,15370,0)
- +14 ;;=C90.01^^56^644^177
- +15 ;;^UTILITY(U,$J,358.3,15370,1,0)
- +16 ;;=^358.31IA^4^2
- +17 ;;^UTILITY(U,$J,358.3,15370,1,3,0)
- +18 ;;=3^Multiple Myeloma,In Remission
- +19 ;;^UTILITY(U,$J,358.3,15370,1,4,0)
- +20 ;;=4^C90.01
- +21 ;;^UTILITY(U,$J,358.3,15370,2)
- +22 ;;=^267515
- +23 ;;^UTILITY(U,$J,358.3,15371,0)
- +24 ;;=C90.00^^56^644^178
- +25 ;;^UTILITY(U,$J,358.3,15371,1,0)
- +26 ;;=^358.31IA^4^2
- +27 ;;^UTILITY(U,$J,358.3,15371,1,3,0)
- +28 ;;=3^Multiple Myeloma,Not in Remission
- +29 ;;^UTILITY(U,$J,358.3,15371,1,4,0)
- +30 ;;=4^C90.00
- +31 ;;^UTILITY(U,$J,358.3,15371,2)
- +32 ;;=^5001752
- +33 ;;^UTILITY(U,$J,358.3,15372,0)
- +34 ;;=C94.6^^56^644^179
- +35 ;;^UTILITY(U,$J,358.3,15372,1,0)
- +36 ;;=^358.31IA^4^2
- +37 ;;^UTILITY(U,$J,358.3,15372,1,3,0)
- +38 ;;=3^Myelodysplastic Disease NEC
- +39 ;;^UTILITY(U,$J,358.3,15372,1,4,0)
- +40 ;;=4^C94.6
- +41 ;;^UTILITY(U,$J,358.3,15372,2)
- +42 ;;=^5001846
- +43 ;;^UTILITY(U,$J,358.3,15373,0)
- +44 ;;=D61.82^^56^644^180
- +45 ;;^UTILITY(U,$J,358.3,15373,1,0)
- +46 ;;=^358.31IA^4^2
- +47 ;;^UTILITY(U,$J,358.3,15373,1,3,0)
- +48 ;;=3^Myelophthisis
- +49 ;;^UTILITY(U,$J,358.3,15373,1,4,0)
- +50 ;;=4^D61.82
- +51 ;;^UTILITY(U,$J,358.3,15373,2)
- +52 ;;=^334037
- +53 ;;^UTILITY(U,$J,358.3,15374,0)
- +54 ;;=D47.9^^56^644^181
- +55 ;;^UTILITY(U,$J,358.3,15374,1,0)
- +56 ;;=^358.31IA^4^2
- +57 ;;^UTILITY(U,$J,358.3,15374,1,3,0)
- +58 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
- +59 ;;^UTILITY(U,$J,358.3,15374,1,4,0)
- +60 ;;=4^D47.9
- +61 ;;^UTILITY(U,$J,358.3,15374,2)
- +62 ;;=^5002260
- +63 ;;^UTILITY(U,$J,358.3,15375,0)
- +64 ;;=D53.9^^56^644^185
- +65 ;;^UTILITY(U,$J,358.3,15375,1,0)
- +66 ;;=^358.31IA^4^2
- +67 ;;^UTILITY(U,$J,358.3,15375,1,3,0)
- +68 ;;=3^Nutritional Anemia,Unspec
- +69 ;;^UTILITY(U,$J,358.3,15375,1,4,0)
- +70 ;;=4^D53.9
- +71 ;;^UTILITY(U,$J,358.3,15375,2)
- +72 ;;=^5002298
- +73 ;;^UTILITY(U,$J,358.3,15376,0)
- +74 ;;=D47.4^^56^644^186
- +75 ;;^UTILITY(U,$J,358.3,15376,1,0)
- +76 ;;=^358.31IA^4^2
- +77 ;;^UTILITY(U,$J,358.3,15376,1,3,0)
- +78 ;;=3^Osteomyelofibrosis
- +79 ;;^UTILITY(U,$J,358.3,15376,1,4,0)
- +80 ;;=4^D47.4
- +81 ;;^UTILITY(U,$J,358.3,15376,2)
- +82 ;;=^5002259
- +83 ;;^UTILITY(U,$J,358.3,15377,0)
- +84 ;;=D51.3^^56^644^210
- +85 ;;^UTILITY(U,$J,358.3,15377,1,0)
- +86 ;;=^358.31IA^4^2
- +87 ;;^UTILITY(U,$J,358.3,15377,1,3,0)
- +88 ;;=3^Vitamin B12 Deficiency Anemia,Other
- +89 ;;^UTILITY(U,$J,358.3,15377,1,4,0)
- +90 ;;=4^D51.3
- +91 ;;^UTILITY(U,$J,358.3,15377,2)
- +92 ;;=^5002287
- +93 ;;^UTILITY(U,$J,358.3,15378,0)
- +94 ;;=D77.^^56^644^62
- +95 ;;^UTILITY(U,$J,358.3,15378,1,0)
- +96 ;;=^358.31IA^4^2
- +97 ;;^UTILITY(U,$J,358.3,15378,1,3,0)
- +98 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
- +99 ;;^UTILITY(U,$J,358.3,15378,1,4,0)
- +100 ;;=4^D77.
- +101 ;;^UTILITY(U,$J,358.3,15378,2)
- +102 ;;=^5002396
- +103 ;;^UTILITY(U,$J,358.3,15379,0)
- +104 ;;=D58.2^^56^644^88
- +105 ;;^UTILITY(U,$J,358.3,15379,1,0)
- +106 ;;=^358.31IA^4^2
- +107 ;;^UTILITY(U,$J,358.3,15379,1,3,0)
- +108 ;;=3^Hemoglobinopathies,Other
- +109 ;;^UTILITY(U,$J,358.3,15379,1,4,0)
- +110 ;;=4^D58.2
- +111 ;;^UTILITY(U,$J,358.3,15379,2)
- +112 ;;=^87629
- +113 ;;^UTILITY(U,$J,358.3,15380,0)
- +114 ;;=C88.8^^56^644^110
- +115 ;;^UTILITY(U,$J,358.3,15380,1,0)
- +116 ;;=^358.31IA^4^2
- +117 ;;^UTILITY(U,$J,358.3,15380,1,3,0)
- +118 ;;=3^Malig Immunoproliferative Diseases,Other
- +119 ;;^UTILITY(U,$J,358.3,15380,1,4,0)
- +120 ;;=4^C88.8
- +121 ;;^UTILITY(U,$J,358.3,15380,2)
- +122 ;;=^5001750
- +123 ;;^UTILITY(U,$J,358.3,15381,0)
- +124 ;;=D70.8^^56^644^183
- +125 ;;^UTILITY(U,$J,358.3,15381,1,0)
- +126 ;;=^358.31IA^4^2
- +127 ;;^UTILITY(U,$J,358.3,15381,1,3,0)
- +128 ;;=3^Neutropenia,Other
- +129 ;;^UTILITY(U,$J,358.3,15381,1,4,0)
- +130 ;;=4^D70.8
- +131 ;;^UTILITY(U,$J,358.3,15381,2)
- +132 ;;=^334042
- +133 ;;^UTILITY(U,$J,358.3,15382,0)
- +134 ;;=D59.4^^56^644^184
- +135 ;;^UTILITY(U,$J,358.3,15382,1,0)
- +136 ;;=^358.31IA^4^2
- +137 ;;^UTILITY(U,$J,358.3,15382,1,3,0)
- +138 ;;=3^Nonautoimmune Hemolytic Anemias,Other
- +139 ;;^UTILITY(U,$J,358.3,15382,1,4,0)
- +140 ;;=4^D59.4
- +141 ;;^UTILITY(U,$J,358.3,15382,2)
- +142 ;;=^5002326
- +143 ;;^UTILITY(U,$J,358.3,15383,0)
- +144 ;;=D69.59^^56^644^190
- +145 ;;^UTILITY(U,$J,358.3,15383,1,0)
- +146 ;;=^358.31IA^4^2
- +147 ;;^UTILITY(U,$J,358.3,15383,1,3,0)
- +148 ;;=3^Secondary Thrombocytopenia,Other
- +149 ;;^UTILITY(U,$J,358.3,15383,1,4,0)
- +150 ;;=4^D69.59
- +151 ;;^UTILITY(U,$J,358.3,15383,2)
- +152 ;;=^5002369
- +153 ;;^UTILITY(U,$J,358.3,15384,0)
- +154 ;;=C22.7^^56^644^51
- +155 ;;^UTILITY(U,$J,358.3,15384,1,0)
- +156 ;;=^358.31IA^4^2
- +157 ;;^UTILITY(U,$J,358.3,15384,1,3,0)
- +158 ;;=3^Carcinomas of Liver,Other Spec
- +159 ;;^UTILITY(U,$J,358.3,15384,1,4,0)
- +160 ;;=4^C22.7
- +161 ;;^UTILITY(U,$J,358.3,15384,2)
- +162 ;;=^5000938
- +163 ;;^UTILITY(U,$J,358.3,15385,0)
- +164 ;;=D75.89^^56^644^61
- +165 ;;^UTILITY(U,$J,358.3,15385,1,0)
- +166 ;;=^358.31IA^4^2
- +167 ;;^UTILITY(U,$J,358.3,15385,1,3,0)
- +168 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
- +169 ;;^UTILITY(U,$J,358.3,15385,1,4,0)
- +170 ;;=4^D75.89
- +171 ;;^UTILITY(U,$J,358.3,15385,2)
- +172 ;;=^5002392
- +173 ;;^UTILITY(U,$J,358.3,15386,0)
- +174 ;;=D47.Z9^^56^644^182
- +175 ;;^UTILITY(U,$J,358.3,15386,1,0)
- +176 ;;=^358.31IA^4^2
- +177 ;;^UTILITY(U,$J,358.3,15386,1,3,0)
- +178 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
- +179 ;;^UTILITY(U,$J,358.3,15386,1,4,0)
- +180 ;;=4^D47.Z9
- +181 ;;^UTILITY(U,$J,358.3,15386,2)
- +182 ;;=^5002262
- +183 ;;^UTILITY(U,$J,358.3,15387,0)
- +184 ;;=D05.82^^56^644^39
- +185 ;;^UTILITY(U,$J,358.3,15387,1,0)
- +186 ;;=^358.31IA^4^2
- +187 ;;^UTILITY(U,$J,358.3,15387,1,3,0)
- +188 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
- +189 ;;^UTILITY(U,$J,358.3,15387,1,4,0)
- +190 ;;=4^D05.82
- +191 ;;^UTILITY(U,$J,358.3,15387,2)
- +192 ;;=^5001934
- +193 ;;^UTILITY(U,$J,358.3,15388,0)
- +194 ;;=D05.81^^56^644^41
- +195 ;;^UTILITY(U,$J,358.3,15388,1,0)
- +196 ;;=^358.31IA^4^2
- +197 ;;^UTILITY(U,$J,358.3,15388,1,3,0)
- +198 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
- +199 ;;^UTILITY(U,$J,358.3,15388,1,4,0)
- +200 ;;=4^D05.81
- +201 ;;^UTILITY(U,$J,358.3,15388,2)
- +202 ;;=^5001933
- +203 ;;^UTILITY(U,$J,358.3,15389,0)
- +204 ;;=D05.80^^56^644^43
- +205 ;;^UTILITY(U,$J,358.3,15389,1,0)
- +206 ;;=^358.31IA^4^2
- +207 ;;^UTILITY(U,$J,358.3,15389,1,3,0)
- +208 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
- +209 ;;^UTILITY(U,$J,358.3,15389,1,4,0)
- +210 ;;=4^D05.80
- +211 ;;^UTILITY(U,$J,358.3,15389,2)
- +212 ;;=^5001932
- +213 ;;^UTILITY(U,$J,358.3,15390,0)
- +214 ;;=D56.8^^56^644^205
- +215 ;;^UTILITY(U,$J,358.3,15390,1,0)
- +216 ;;=^358.31IA^4^2
- +217 ;;^UTILITY(U,$J,358.3,15390,1,3,0)
- +218 ;;=3^Thalassemias,Other
- +219 ;;^UTILITY(U,$J,358.3,15390,1,4,0)
- +220 ;;=4^D56.8
- +221 ;;^UTILITY(U,$J,358.3,15390,2)
- +222 ;;=^5002305
- +223 ;;^UTILITY(U,$J,358.3,15391,0)
- +224 ;;=C82.89^^56^644^81
- +225 ;;^UTILITY(U,$J,358.3,15391,1,0)
- +226 ;;=^358.31IA^4^2
- +227 ;;^UTILITY(U,$J,358.3,15391,1,3,0)
- +228 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
- +229 ;;^UTILITY(U,$J,358.3,15391,1,4,0)
- +230 ;;=4^C82.89
- +231 ;;^UTILITY(U,$J,358.3,15391,2)
- +232 ;;=^5001540
- +233 ;;^UTILITY(U,$J,358.3,15392,0)
- +234 ;;=D51.8^^56^644^212
- +235 ;;^UTILITY(U,$J,358.3,15392,1,0)
- +236 ;;=^358.31IA^4^2
- +237 ;;^UTILITY(U,$J,358.3,15392,1,3,0)
- +238 ;;=3^Vitamin B12 Deficiency Anemias,Other
- +239 ;;^UTILITY(U,$J,358.3,15392,1,4,0)
- +240 ;;=4^D51.8
- +241 ;;^UTILITY(U,$J,358.3,15392,2)
- +242 ;;=^5002288
- +243 ;;^UTILITY(U,$J,358.3,15393,0)
- +244 ;;=I80.9^^56^644^187
- +245 ;;^UTILITY(U,$J,358.3,15393,1,0)
- +246 ;;=^358.31IA^4^2
- +247 ;;^UTILITY(U,$J,358.3,15393,1,3,0)
- +248 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
- +249 ;;^UTILITY(U,$J,358.3,15393,1,4,0)
- +250 ;;=4^I80.9
- +251 ;;^UTILITY(U,$J,358.3,15393,2)
- +252 ;;=^93357
- +253 ;;^UTILITY(U,$J,358.3,15394,0)
- +254 ;;=D45.^^56^644^188
- +255 ;;^UTILITY(U,$J,358.3,15394,1,0)
- +256 ;;=^358.31IA^4^2
- +257 ;;^UTILITY(U,$J,358.3,15394,1,3,0)
- +258 ;;=3^Polycythemia Vera
- +259 ;;^UTILITY(U,$J,358.3,15394,1,4,0)
- +260 ;;=4^D45.
- +261 ;;^UTILITY(U,$J,358.3,15394,2)
- +262 ;;=^96105
- +263 ;;^UTILITY(U,$J,358.3,15395,0)
- +264 ;;=C77.3^^56^644^117
- +265 ;;^UTILITY(U,$J,358.3,15395,1,0)
- +266 ;;=^358.31IA^4^2
- +267 ;;^UTILITY(U,$J,358.3,15395,1,3,0)
- +268 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
- +269 ;;^UTILITY(U,$J,358.3,15395,1,4,0)
- +270 ;;=4^C77.3
- +271 ;;^UTILITY(U,$J,358.3,15395,2)
- +272 ;;=^5001330
- +273 ;;^UTILITY(U,$J,358.3,15396,0)
- +274 ;;=C77.2^^56^644^133
- +275 ;;^UTILITY(U,$J,358.3,15396,1,0)
- +276 ;;=^358.31IA^4^2
- +277 ;;^UTILITY(U,$J,358.3,15396,1,3,0)
- +278 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
- +279 ;;^UTILITY(U,$J,358.3,15396,1,4,0)
- +280 ;;=4^C77.2
- +281 ;;^UTILITY(U,$J,358.3,15396,2)
- +282 ;;=^267316
- +283 ;;^UTILITY(U,$J,358.3,15397,0)
- +284 ;;=C77.1^^56^644^134
- +285 ;;^UTILITY(U,$J,358.3,15397,1,0)
- +286 ;;=^358.31IA^4^2
- +287 ;;^UTILITY(U,$J,358.3,15397,1,3,0)
- +288 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
- +289 ;;^UTILITY(U,$J,358.3,15397,1,4,0)
- +290 ;;=4^C77.1
- +291 ;;^UTILITY(U,$J,358.3,15397,2)
- +292 ;;=^267315
- +293 ;;^UTILITY(U,$J,358.3,15398,0)
- +294 ;;=C77.0^^56^644^150
- +295 ;;^UTILITY(U,$J,358.3,15398,1,0)
- +296 ;;=^358.31IA^4^2
- +297 ;;^UTILITY(U,$J,358.3,15398,1,3,0)
- +298 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
- +299 ;;^UTILITY(U,$J,358.3,15398,1,4,0)
- +300 ;;=4^C77.0
- +301 ;;^UTILITY(U,$J,358.3,15398,2)
- +302 ;;=^5001329
- +303 ;;^UTILITY(U,$J,358.3,15399,0)
- +304 ;;=C77.8^^56^644^151
- +305 ;;^UTILITY(U,$J,358.3,15399,1,0)
- +306 ;;=^358.31IA^4^2
- +307 ;;^UTILITY(U,$J,358.3,15399,1,3,0)
- +308 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
- +309 ;;^UTILITY(U,$J,358.3,15399,1,4,0)
- +310 ;;=4^C77.8
- +311 ;;^UTILITY(U,$J,358.3,15399,2)
- +312 ;;=^5001332
- +313 ;;^UTILITY(U,$J,358.3,15400,0)
- +314 ;;=C79.51^^56^644^121
- +315 ;;^UTILITY(U,$J,358.3,15400,1,0)
- +316 ;;=^358.31IA^4^2
- +317 ;;^UTILITY(U,$J,358.3,15400,1,3,0)
- +318 ;;=3^Malig Neop Bone,Secondary
- +319 ;;^UTILITY(U,$J,358.3,15400,1,4,0)
- +320 ;;=4^C79.51
- +321 ;;^UTILITY(U,$J,358.3,15400,2)
- +322 ;;=^5001350
- +323 ;;^UTILITY(U,$J,358.3,15401,0)
- +324 ;;=C79.52^^56^644^120
- +325 ;;^UTILITY(U,$J,358.3,15401,1,0)
- +326 ;;=^358.31IA^4^2
- +327 ;;^UTILITY(U,$J,358.3,15401,1,3,0)
- +328 ;;=3^Malig Neop Bone Marrow,Secondary
- +329 ;;^UTILITY(U,$J,358.3,15401,1,4,0)
- +330 ;;=4^C79.52
- +331 ;;^UTILITY(U,$J,358.3,15401,2)
- +332 ;;=^5001351
- +333 ;;^UTILITY(U,$J,358.3,15402,0)
- +334 ;;=C79.31^^56^644^122
- +335 ;;^UTILITY(U,$J,358.3,15402,1,0)
- +336 ;;=^358.31IA^4^2
- +337 ;;^UTILITY(U,$J,358.3,15402,1,3,0)
- +338 ;;=3^Malig Neop Brain,Secondary
- +339 ;;^UTILITY(U,$J,358.3,15402,1,4,0)
- +340 ;;=4^C79.31
- +341 ;;^UTILITY(U,$J,358.3,15402,2)
- +342 ;;=^5001347
- +343 ;;^UTILITY(U,$J,358.3,15403,0)
- +344 ;;=C79.72^^56^644^137
- +345 ;;^UTILITY(U,$J,358.3,15403,1,0)
- +346 ;;=^358.31IA^4^2
- +347 ;;^UTILITY(U,$J,358.3,15403,1,3,0)
- +348 ;;=3^Malig Neop Left Adrenal Gland,Secondary
- +349 ;;^UTILITY(U,$J,358.3,15403,1,4,0)
- +350 ;;=4^C79.72
- +351 ;;^UTILITY(U,$J,358.3,15403,2)
- +352 ;;=^5001357
- +353 ;;^UTILITY(U,$J,358.3,15404,0)
- +354 ;;=C78.02^^56^644^141
- +355 ;;^UTILITY(U,$J,358.3,15404,1,0)
- +356 ;;=^358.31IA^4^2
- +357 ;;^UTILITY(U,$J,358.3,15404,1,3,0)
- +358 ;;=3^Malig Neop Left Lung,Secondary
- +359 ;;^UTILITY(U,$J,358.3,15404,1,4,0)
- +360 ;;=4^C78.02
- +361 ;;^UTILITY(U,$J,358.3,15404,2)
- +362 ;;=^5001336
- +363 ;;^UTILITY(U,$J,358.3,15405,0)
- +364 ;;=C78.7^^56^644^146
- +365 ;;^UTILITY(U,$J,358.3,15405,1,0)
- +366 ;;=^358.31IA^4^2
- +367 ;;^UTILITY(U,$J,358.3,15405,1,3,0)
- +368 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
- +369 ;;^UTILITY(U,$J,358.3,15405,1,4,0)
- +370 ;;=4^C78.7
- +371 ;;^UTILITY(U,$J,358.3,15405,2)
- +372 ;;=^5001339
- +373 ;;^UTILITY(U,$J,358.3,15406,0)
- +374 ;;=C79.71^^56^644^159
- +375 ;;^UTILITY(U,$J,358.3,15406,1,0)
- +376 ;;=^358.31IA^4^2
- +377 ;;^UTILITY(U,$J,358.3,15406,1,3,0)
- +378 ;;=3^Malig Neop Right Adrenal Gland,Secondary
- +379 ;;^UTILITY(U,$J,358.3,15406,1,4,0)
- +380 ;;=4^C79.71
- +381 ;;^UTILITY(U,$J,358.3,15406,2)
- +382 ;;=^5001356
- +383 ;;^UTILITY(U,$J,358.3,15407,0)
- +384 ;;=C78.01^^56^644^163
- +385 ;;^UTILITY(U,$J,358.3,15407,1,0)
- +386 ;;=^358.31IA^4^2
- +387 ;;^UTILITY(U,$J,358.3,15407,1,3,0)
- +388 ;;=3^Malig Neop Right Lung,Secondary
- +389 ;;^UTILITY(U,$J,358.3,15407,1,4,0)
- +390 ;;=4^C78.01
- +391 ;;^UTILITY(U,$J,358.3,15407,2)
- +392 ;;=^5001335
- +393 ;;^UTILITY(U,$J,358.3,15408,0)
- +394 ;;=C79.70^^56^644^114
- +395 ;;^UTILITY(U,$J,358.3,15408,1,0)
- +396 ;;=^358.31IA^4^2
- +397 ;;^UTILITY(U,$J,358.3,15408,1,3,0)
- +398 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
- +399 ;;^UTILITY(U,$J,358.3,15408,1,4,0)
- +400 ;;=4^C79.70
- +401 ;;^UTILITY(U,$J,358.3,15408,2)
- +402 ;;=^5001355
- +403 ;;^UTILITY(U,$J,358.3,15409,0)
- +404 ;;=C78.00^^56^644^147
- +405 ;;^UTILITY(U,$J,358.3,15409,1,0)
- +406 ;;=^358.31IA^4^2
- +407 ;;^UTILITY(U,$J,358.3,15409,1,3,0)
- +408 ;;=3^Malig Neop Lung Unspec,Secondary
- +409 ;;^UTILITY(U,$J,358.3,15409,1,4,0)
- +410 ;;=4^C78.00
- +411 ;;^UTILITY(U,$J,358.3,15409,2)
- +412 ;;=^5001334
- +413 ;;^UTILITY(U,$J,358.3,15410,0)
- +414 ;;=D57.1^^56^644^191
- +415 ;;^UTILITY(U,$J,358.3,15410,1,0)
- +416 ;;=^358.31IA^4^2
- +417 ;;^UTILITY(U,$J,358.3,15410,1,3,0)
- +418 ;;=3^Sickle-Cell Disease w/o Crisis
- +419 ;;^UTILITY(U,$J,358.3,15410,1,4,0)
- +420 ;;=4^D57.1
- +421 ;;^UTILITY(U,$J,358.3,15410,2)
- +422 ;;=^5002309
- +423 ;;^UTILITY(U,$J,358.3,15411,0)
- +424 ;;=D75.1^^56^644^189
- +425 ;;^UTILITY(U,$J,358.3,15411,1,0)
- +426 ;;=^358.31IA^4^2
- +427 ;;^UTILITY(U,$J,358.3,15411,1,3,0)
- +428 ;;=3^Polycythemia,Secondary
- +429 ;;^UTILITY(U,$J,358.3,15411,1,4,0)
- +430 ;;=4^D75.1
- +431 ;;^UTILITY(U,$J,358.3,15411,2)
- +432 ;;=^186856
- +433 ;;^UTILITY(U,$J,358.3,15412,0)
- +434 ;;=C90.30^^56^644^202
- +435 ;;^UTILITY(U,$J,358.3,15412,1,0)
- +436 ;;=^358.31IA^4^2
- +437 ;;^UTILITY(U,$J,358.3,15412,1,3,0)
- +438 ;;=3^Solitary Plasmacytoma,Not in Remission
- +439 ;;^UTILITY(U,$J,358.3,15412,1,4,0)
- +440 ;;=4^C90.30
- +441 ;;^UTILITY(U,$J,358.3,15412,2)
- +442 ;;=^5001759
- +443 ;;^UTILITY(U,$J,358.3,15413,0)
- +444 ;;=D56.3^^56^644^203
- +445 ;;^UTILITY(U,$J,358.3,15413,1,0)
- +446 ;;=^358.31IA^4^2
- +447 ;;^UTILITY(U,$J,358.3,15413,1,3,0)
- +448 ;;=3^Thalassemia Minor
- +449 ;;^UTILITY(U,$J,358.3,15413,1,4,0)
- +450 ;;=4^D56.3
- +451 ;;^UTILITY(U,$J,358.3,15413,2)
- +452 ;;=^340497
- +453 ;;^UTILITY(U,$J,358.3,15414,0)
- +454 ;;=D56.9^^56^644^204
- +455 ;;^UTILITY(U,$J,358.3,15414,1,0)
- +456 ;;=^358.31IA^4^2
- +457 ;;^UTILITY(U,$J,358.3,15414,1,3,0)
- +458 ;;=3^Thalassemia,Unspec
- +459 ;;^UTILITY(U,$J,358.3,15414,1,4,0)
- +460 ;;=4^D56.9
- +461 ;;^UTILITY(U,$J,358.3,15414,2)
- +462 ;;=^340606
- +463 ;;^UTILITY(U,$J,358.3,15415,0)
- +464 ;;=D51.2^^56^644^207
- +465 ;;^UTILITY(U,$J,358.3,15415,1,0)
- +466 ;;=^358.31IA^4^2
- +467 ;;^UTILITY(U,$J,358.3,15415,1,3,0)
- +468 ;;=3^Transcobalamin II Deficiency
- +469 ;;^UTILITY(U,$J,358.3,15415,1,4,0)
- +470 ;;=4^D51.2
- +471 ;;^UTILITY(U,$J,358.3,15415,2)
- +472 ;;=^5002286
- +473 ;;^UTILITY(U,$J,358.3,15416,0)
- +474 ;;=D05.92^^56^644^40
- +475 ;;^UTILITY(U,$J,358.3,15416,1,0)
- +476 ;;=^358.31IA^4^2
- +477 ;;^UTILITY(U,$J,358.3,15416,1,3,0)
- +478 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
- +479 ;;^UTILITY(U,$J,358.3,15416,1,4,0)
- +480 ;;=4^D05.92
- +481 ;;^UTILITY(U,$J,358.3,15416,2)
- +482 ;;=^5001937
- +483 ;;^UTILITY(U,$J,358.3,15417,0)
- +484 ;;=D05.91^^56^644^42
- +485 ;;^UTILITY(U,$J,358.3,15417,1,0)
- +486 ;;=^358.31IA^4^2
- +487 ;;^UTILITY(U,$J,358.3,15417,1,3,0)
- +488 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
- +489 ;;^UTILITY(U,$J,358.3,15417,1,4,0)
- +490 ;;=4^D05.91
- +491 ;;^UTILITY(U,$J,358.3,15417,2)
- +492 ;;=^5001936
- +493 ;;^UTILITY(U,$J,358.3,15418,0)
- +494 ;;=D05.90^^56^644^38
- +495 ;;^UTILITY(U,$J,358.3,15418,1,0)
- +496 ;;=^358.31IA^4^2
- +497 ;;^UTILITY(U,$J,358.3,15418,1,3,0)
- +498 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
- +499 ;;^UTILITY(U,$J,358.3,15418,1,4,0)
- +500 ;;=4^D05.90
- +501 ;;^UTILITY(U,$J,358.3,15418,2)
- +502 ;;=^5001935
- +503 ;;^UTILITY(U,$J,358.3,15419,0)
- +504 ;;=D51.0^^56^644^208
- +505 ;;^UTILITY(U,$J,358.3,15419,1,0)
- +506 ;;=^358.31IA^4^2
- +507 ;;^UTILITY(U,$J,358.3,15419,1,3,0)
- +508 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
- +509 ;;^UTILITY(U,$J,358.3,15419,1,4,0)
- +510 ;;=4^D51.0
- +511 ;;^UTILITY(U,$J,358.3,15419,2)
- +512 ;;=^5002284
- +513 ;;^UTILITY(U,$J,358.3,15420,0)
- +514 ;;=D51.1^^56^644^209
- +515 ;;^UTILITY(U,$J,358.3,15420,1,0)
- +516 ;;=^358.31IA^4^2
- +517 ;;^UTILITY(U,$J,358.3,15420,1,3,0)
- +518 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
- +519 ;;^UTILITY(U,$J,358.3,15420,1,4,0)
- +520 ;;=4^D51.1
- +521 ;;^UTILITY(U,$J,358.3,15420,2)
- +522 ;;=^5002285
- +523 ;;^UTILITY(U,$J,358.3,15421,0)
- +524 ;;=D51.9^^56^644^211
- +525 ;;^UTILITY(U,$J,358.3,15421,1,0)
- +526 ;;=^358.31IA^4^2
- +527 ;;^UTILITY(U,$J,358.3,15421,1,3,0)
- +528 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
- +529 ;;^UTILITY(U,$J,358.3,15421,1,4,0)
- +530 ;;=4^D51.9
- +531 ;;^UTILITY(U,$J,358.3,15421,2)
- +532 ;;=^5002289
- +533 ;;^UTILITY(U,$J,358.3,15422,0)
- +534 ;;=D68.0^^56^644^213
- +535 ;;^UTILITY(U,$J,358.3,15422,1,0)
- +536 ;;=^358.31IA^4^2
- +537 ;;^UTILITY(U,$J,358.3,15422,1,3,0)
- +538 ;;=3^Von Willebrand's Disease
- +539 ;;^UTILITY(U,$J,358.3,15422,1,4,0)
- +540 ;;=4^D68.0
- +541 ;;^UTILITY(U,$J,358.3,15422,2)
- +542 ;;=^127267
- +543 ;;^UTILITY(U,$J,358.3,15423,0)
- +544 ;;=C88.0^^56^644^214
- +545 ;;^UTILITY(U,$J,358.3,15423,1,0)
- +546 ;;=^358.31IA^4^2
- +547 ;;^UTILITY(U,$J,358.3,15423,1,3,0)
- +548 ;;=3^Waldenstrom Macroglobulinemia
- +549 ;;^UTILITY(U,$J,358.3,15423,1,4,0)
- +550 ;;=4^C88.0
- +551 ;;^UTILITY(U,$J,358.3,15423,2)
- +552 ;;=^5001748
- +553 ;;^UTILITY(U,$J,358.3,15424,0)
- +554 ;;=C91.02^^56^644^3
- +555 ;;^UTILITY(U,$J,358.3,15424,1,0)
- +556 ;;=^358.31IA^4^2
- +557 ;;^UTILITY(U,$J,358.3,15424,1,3,0)
- +558 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
- +559 ;;^UTILITY(U,$J,358.3,15424,1,4,0)
- +560 ;;=4^C91.02
- +561 ;;^UTILITY(U,$J,358.3,15424,2)
- +562 ;;=^5001764
- +563 ;;^UTILITY(U,$J,358.3,15425,0)
- +564 ;;=C92.02^^56^644^6
- +565 ;;^UTILITY(U,$J,358.3,15425,1,0)
- +566 ;;=^358.31IA^4^2
- +567 ;;^UTILITY(U,$J,358.3,15425,1,3,0)
- +568 ;;=3^Acute Myeloblastic Leukemia,In Relapse
- +569 ;;^UTILITY(U,$J,358.3,15425,1,4,0)
- +570 ;;=4^C92.02
- +571 ;;^UTILITY(U,$J,358.3,15425,2)
- +572 ;;=^5001791
- +573 ;;^UTILITY(U,$J,358.3,15426,0)
- +574 ;;=D09.3^^56^644^50
- +575 ;;^UTILITY(U,$J,358.3,15426,1,0)
- +576 ;;=^358.31IA^4^2
- +577 ;;^UTILITY(U,$J,358.3,15426,1,3,0)
- +578 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
- +579 ;;^UTILITY(U,$J,358.3,15426,1,4,0)
- +580 ;;=4^D09.3
- +581 ;;^UTILITY(U,$J,358.3,15426,2)
- +582 ;;=^5001955
- +583 ;;^UTILITY(U,$J,358.3,15427,0)
- +584 ;;=C22.0^^56^644^91
- +585 ;;^UTILITY(U,$J,358.3,15427,1,0)
- +586 ;;=^358.31IA^4^2
- +587 ;;^UTILITY(U,$J,358.3,15427,1,3,0)
- +588 ;;=3^Hepatocellular Carcinoma
- +589 ;;^UTILITY(U,$J,358.3,15427,1,4,0)
- +590 ;;=4^C22.0
- +591 ;;^UTILITY(U,$J,358.3,15427,2)
- +592 ;;=^5000933
- +593 ;;^UTILITY(U,$J,358.3,15428,0)
- +594 ;;=C24.9^^56^644^118
- +595 ;;^UTILITY(U,$J,358.3,15428,1,0)
- +596 ;;=^358.31IA^4^2
- +597 ;;^UTILITY(U,$J,358.3,15428,1,3,0)
- +598 ;;=3^Malig Neop Biliary Tract,Unspec
- +599 ;;^UTILITY(U,$J,358.3,15428,1,4,0)
- +600 ;;=4^C24.9
- +601 ;;^UTILITY(U,$J,358.3,15428,2)
- +602 ;;=^5000942
- +603 ;;^UTILITY(U,$J,358.3,15429,0)
- +604 ;;=C50.922^^56^644^142
- +605 ;;^UTILITY(U,$J,358.3,15429,1,0)
- +606 ;;=^358.31IA^4^2
- +607 ;;^UTILITY(U,$J,358.3,15429,1,3,0)
- +608 ;;=3^Malig Neop Left Male Breast,Unspec Site
- +609 ;;^UTILITY(U,$J,358.3,15429,1,4,0)
- +610 ;;=4^C50.922
- +611 ;;^UTILITY(U,$J,358.3,15429,2)
- +612 ;;=^5133340
- +613 ;;^UTILITY(U,$J,358.3,15430,0)
- +614 ;;=C34.91^^56^644^160
- +615 ;;^UTILITY(U,$J,358.3,15430,1,0)
- +616 ;;=^358.31IA^4^2
- +617 ;;^UTILITY(U,$J,358.3,15430,1,3,0)
- +618 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
- +619 ;;^UTILITY(U,$J,358.3,15430,1,4,0)
- +620 ;;=4^C34.91
- +621 ;;^UTILITY(U,$J,358.3,15430,2)
- +622 ;;=^5000967
- +623 ;;^UTILITY(U,$J,358.3,15431,0)
- +624 ;;=C50.921^^56^644^164
- +625 ;;^UTILITY(U,$J,358.3,15431,1,0)
- +626 ;;=^358.31IA^4^2
- +627 ;;^UTILITY(U,$J,358.3,15431,1,3,0)
- +628 ;;=3^Malig Neop Right Male Breast,Unspec Site
- +629 ;;^UTILITY(U,$J,358.3,15431,1,4,0)
- +630 ;;=4^C50.921
- +631 ;;^UTILITY(U,$J,358.3,15431,2)
- +632 ;;=^5001198
- +633 ;;^UTILITY(U,$J,358.3,15432,0)
- +634 ;;=C90.02^^56^644^176
- +635 ;;^UTILITY(U,$J,358.3,15432,1,0)
- +636 ;;=^358.31IA^4^2
- +637 ;;^UTILITY(U,$J,358.3,15432,1,3,0)
- +638 ;;=3^Multiple Myeloma,In Relapse
- +639 ;;^UTILITY(U,$J,358.3,15432,1,4,0)
- +640 ;;=4^C90.02
- +641 ;;^UTILITY(U,$J,358.3,15432,2)
- +642 ;;=^5001753
- +643 ;;^UTILITY(U,$J,358.3,15433,0)
- +644 ;;=D51.9^^56^644^25
- +645 ;;^UTILITY(U,$J,358.3,15433,1,0)
- +646 ;;=^358.31IA^4^2
- +647 ;;^UTILITY(U,$J,358.3,15433,1,3,0)
- +648 ;;=3^Anemia in Vitamin B12 Deficiency
- +649 ;;^UTILITY(U,$J,358.3,15433,1,4,0)
- +650 ;;=4^D51.9
- +651 ;;^UTILITY(U,$J,358.3,15433,2)
- +652 ;;=^5002289
- +653 ;;^UTILITY(U,$J,358.3,15434,0)
- +654 ;;=C79.51^^56^644^35
- +655 ;;^UTILITY(U,$J,358.3,15434,1,0)
- +656 ;;=^358.31IA^4^2
- +657 ;;^UTILITY(U,$J,358.3,15434,1,3,0)
- +658 ;;=3^Bone Mets
- +659 ;;^UTILITY(U,$J,358.3,15434,1,4,0)
- +660 ;;=4^C79.51
- +661 ;;^UTILITY(U,$J,358.3,15434,2)
- +662 ;;=^5001350
- +663 ;;^UTILITY(U,$J,358.3,15435,0)
- +664 ;;=C80.1^^56^644^171
- +665 ;;^UTILITY(U,$J,358.3,15435,1,0)
- +666 ;;=^358.31IA^4^2
- +667 ;;^UTILITY(U,$J,358.3,15435,1,3,0)
- +668 ;;=3^Malig Neop,Primary,Unspec Site
- +669 ;;^UTILITY(U,$J,358.3,15435,1,4,0)
- +670 ;;=4^C80.1
- +671 ;;^UTILITY(U,$J,358.3,15435,2)
- +672 ;;=^5001389
- +673 ;;^UTILITY(U,$J,358.3,15436,0)
- +674 ;;=C80.0^^56^644^172
- +675 ;;^UTILITY(U,$J,358.3,15436,1,0)
- +676 ;;=^358.31IA^4^2